ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $920 | -25.0% | 34,242 | -0.4% | 0.00% | 0.0% |
Q2 2023 | $1,226 | +41.4% | 34,390 | +0.6% | 0.00% | 0.0% |
Q1 2023 | $867 | +241.3% | 34,172 | +444.9% | 0.00% | +100.0% |
Q4 2022 | $254 | -99.9% | 6,271 | -3.7% | 0.00% | 0.0% |
Q3 2022 | $215,000 | -9.7% | 6,513 | -3.7% | 0.00% | 0.0% |
Q2 2022 | $238,000 | -8.1% | 6,764 | +19.8% | 0.00% | 0.0% |
Q1 2022 | $259,000 | -37.0% | 5,648 | -9.0% | 0.00% | 0.0% |
Q4 2021 | $411,000 | +2.2% | 6,209 | -3.7% | 0.00% | 0.0% |
Q3 2021 | $402,000 | -55.6% | 6,449 | -41.0% | 0.00% | -50.0% |
Q2 2021 | $905,000 | +11.9% | 10,934 | -10.4% | 0.00% | 0.0% |
Q1 2021 | $809,000 | -13.8% | 12,203 | -0.3% | 0.00% | -33.3% |
Q4 2020 | $939,000 | +82.0% | 12,238 | +2.0% | 0.00% | +50.0% |
Q3 2020 | $516,000 | 0.0% | 12,002 | +0.3% | 0.00% | 0.0% |
Q2 2020 | $516,000 | +54.0% | 11,968 | +2.6% | 0.00% | 0.0% |
Q1 2020 | $335,000 | -61.5% | 11,665 | -15.1% | 0.00% | -33.3% |
Q4 2019 | $871,000 | +190.3% | 13,740 | +29.0% | 0.00% | +200.0% |
Q3 2019 | $300,000 | +17.6% | 10,650 | +10.4% | 0.00% | 0.0% |
Q2 2019 | $255,000 | +29.4% | 9,650 | -10.5% | 0.00% | 0.0% |
Q1 2019 | $197,000 | – | 10,785 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |